Prof David Kaye holding up the Total Artificial Heart

News

Allergy
Treasurer Tim Pallas, Emeritus Professor Jenny Rolland, Breakthrough Victoria CEO Grant Dooley, allergy sufferer Aleisha Bannan with baby Stevie, Brandon Capital MD Chris Nave and Professor Robyn O'Hehir gather for the funding announcement.
$12m boost for peanut allergy treatment
24 January 2024
Breakthrough Victoria has invested $12 million to progress Phase 2 clinical trials of a promising peanut allergy treatment, initially developed by Alfred Health and Monash University researchers.
allergy
immunology
patients
research & innovation

Filter by tags

patients course emergency & trauma the alfred foundation research & innovation staff cancer nursing education heart education mental health melanoma intensive care covid-19 cancer research hiv clinical trials events oncology physiotherapy transplant pharmacy brain burns icu allied health donate advance care planning volunteers blood cancers